VRNA - Verona Pharma plc (VRNA) Q1 2024 Earnings Call Transcript
2024-05-09 12:31:02 ET
Verona Pharma plc (VRNA)
Q1 2024 Results Conference Call
May 09, 2024 9:00 AM ET
Company Participants
David Zaccardelli - President, CEO & Executive Director
Mark Hahn - Chief Financial Officer
Christopher Martin - Chief Commercial Officer
Tara Rheault - Chief Development Officer
Conference Call Participants
Andrew Tsai - Jefferies
Tom Shrader - BTIG
Ram Selvaraju - H.C. Wainwright
Presentation
Operator
Hello, and welcome to Verona Pharma's First Quarter 2024 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode. Earlier this morning, Verona Pharma issued a press release announcing its financial results for the 3 months ended March 31, 2024. A copy can be found in the Investor Relations tab on the corporate website, www.veronapharma.com.
Before we begin, I'd like to remind you that during today's call, statements about the company's future expectations, plans and prospects are forward looking statements. These forward looking statements are based on management’s current expectations. These statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from our expectations expressed or implied by the forward-looking statements.
Any such forward-looking statements represent management's estimates as of the date of this conference call. While the company may elect to update such forward-looking statements at some point in the future, it disclaims any obligation to do so even if subsequent events cause its views to change. As a reminder, this call is being recorded and will remain available for 90 days....
Verona Pharma plc (VRNA) Q1 2024 Earnings Call Transcript